Published in Medical Letter on the CDC and FDA, September 10th, 2006
Key quarterly results and recent events include:
- Net revenues of $5.5 million, compared to $6.3 in the second quarter of 2005. Net revenues increased 22% from $4.5 million in the first quarter of 2006.
- Operating expenses of $5.1 million, compared to $5.0 million in the second quarter of 2005. Operating expenses were $4.8 million in the first quarter of 2006.
- Loss from operations of $1.9 million, compared to the loss from operations of $1.0 million in the second quarter of 2005. Loss from operations...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.